NO20060108L - Look-through mutagenesis - Google Patents
Look-through mutagenesisInfo
- Publication number
- NO20060108L NO20060108L NO20060108A NO20060108A NO20060108L NO 20060108 L NO20060108 L NO 20060108L NO 20060108 A NO20060108 A NO 20060108A NO 20060108 A NO20060108 A NO 20060108A NO 20060108 L NO20060108 L NO 20060108L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- libraries
- mutagenesis
- amino acids
- function
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Gram-positive bacteria
- C07K16/1282—Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48328203P | 2003-06-27 | 2003-06-27 | |
| PCT/US2004/020306 WO2005003345A2 (en) | 2003-06-27 | 2004-06-25 | Look-through mutagenesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060108L true NO20060108L (no) | 2006-03-24 |
Family
ID=33563915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060108A NO20060108L (no) | 2003-06-27 | 2006-01-06 | Look-through mutagenesis |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050136428A1 (pt) |
| EP (1) | EP1660655B1 (pt) |
| JP (2) | JP4791960B2 (pt) |
| KR (1) | KR20060034650A (pt) |
| CN (1) | CN1836041A (pt) |
| AU (1) | AU2004254352A1 (pt) |
| BR (1) | BRPI0412007A (pt) |
| CA (1) | CA2542192C (pt) |
| ES (1) | ES2609102T3 (pt) |
| IL (1) | IL172736A0 (pt) |
| NO (1) | NO20060108L (pt) |
| RU (1) | RU2005140664A (pt) |
| WO (1) | WO2005003345A2 (pt) |
| ZA (1) | ZA200510460B (pt) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7329725B1 (en) * | 2003-10-29 | 2008-02-12 | Nastech Pharmaceutical Company Inc. | Phage displayed Trp cage ligands |
| EP1781680B8 (en) | 2004-07-06 | 2016-05-18 | Bioren, LLC | Universal antibody libraries |
| WO2006014477A1 (en) * | 2004-07-06 | 2006-02-09 | Bioren, Inc. | HIGH AFFINITY ANTI-TNF-α ANTIBODIES AND METHOD |
| ATE528396T1 (de) | 2004-07-06 | 2011-10-15 | Bioren Inc | Look-through-mutagenese zur entwicklung veränderter polypeptide mit verbesserten eigenschaften |
| WO2006094234A1 (en) * | 2005-03-03 | 2006-09-08 | Xencor, Inc. | Methods for the design of libraries of protein variants |
| US20080207467A1 (en) * | 2005-03-03 | 2008-08-28 | Xencor, Inc. | Methods for the design of libraries of protein variants |
| CA2605697A1 (en) * | 2005-04-26 | 2006-11-02 | Bioren, Inc. | Method of producing human igg antibodies with enhanced effector functions |
| WO2007019620A1 (en) * | 2005-08-15 | 2007-02-22 | Arana Therapeutics Limited | Engineered antibodies with new world primate framework regions |
| US8716195B2 (en) * | 2005-11-14 | 2014-05-06 | Bioren, Inc. | Antibody ultrahumanization by predicted mature CDR blasting and cohort library generation and screening |
| US20110129414A1 (en) * | 2005-11-15 | 2011-06-02 | Balyasnikova Irina V | Single Chain Fragment of Monoclonal Antibody 9B9 and Uses Thereof |
| US20090286962A1 (en) | 2005-12-20 | 2009-11-19 | Woolven Benjamin P | Chimeric antibodies with part new world primate binding regions |
| NZ569988A (en) | 2006-02-01 | 2011-09-30 | Cephalon Australia Pty Ltd | Domain antibody construct which binds to human TNF-alpha and contains a modified hinge region sequence and a truncated CH1 domain |
| US7704953B2 (en) * | 2006-02-17 | 2010-04-27 | Mdrna, Inc. | Phage displayed cell binding peptides |
| US20070224627A1 (en) * | 2006-03-23 | 2007-09-27 | Lawrence Horowitz | Facilitation of translocation of molecules through the gastrointestinal tract |
| JP2009537147A (ja) | 2006-05-15 | 2009-10-29 | シー レーン バイオテクノロジーズ， エルエルシー | インフルエンザウイルスに対する中和抗体 |
| WO2007136840A2 (en) * | 2006-05-20 | 2007-11-29 | Codon Devices, Inc. | Nucleic acid library design and assembly |
| JP2010500876A (ja) | 2006-08-18 | 2010-01-14 | アブリンクス エン．ヴェー． | Ｉｌ−６媒介性シグナル伝達に関連する疾患及び障害の治療のための、ｉｌ−６ｒに指向性を有するアミノ酸配列及びこれを含むポリペプチド |
| US8131480B2 (en) | 2006-10-02 | 2012-03-06 | Sea Lane Biotechnologies Llc | Construction of diverse synthetic peptide and polypeptide libraries |
| WO2008045380A2 (en) * | 2006-10-04 | 2008-04-17 | Codon Devices, Inc. | Nucleic acid libraries and their design and assembly |
| WO2008153925A2 (en) * | 2007-06-06 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Methods for improving multiple protein properties |
| WO2009009045A2 (en) * | 2007-07-10 | 2009-01-15 | The Scripps Research Institute | Escape libraries of target polypeptides |
| US20090176654A1 (en) * | 2007-08-10 | 2009-07-09 | Protelix, Inc. | Universal fibronectin type III binding-domain libraries |
| US8470966B2 (en) | 2007-08-10 | 2013-06-25 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
| US8680019B2 (en) * | 2007-08-10 | 2014-03-25 | Protelica, Inc. | Universal fibronectin Type III binding-domain libraries |
| CA2706425A1 (en) | 2007-11-27 | 2009-06-04 | Ablynx N.V. | Method for obtaining polypeptide constructs comprising two or more single domain antibodies |
| CA2719201A1 (en) | 2008-03-28 | 2009-10-01 | Sea Lane Biotechnologies, Llc. | Neutralizing molecules to viral antigens |
| EP2131244A3 (en) * | 2008-06-02 | 2012-04-11 | ASML Netherlands BV | Lithographic apparatus and method for measuring a pattern property |
| MX2011010681A (es) | 2009-04-10 | 2012-01-20 | Ablynx Nv | Secuencias mejoradas de aminoacidos dirigidas contra il-6r y polipeptidos que comprenden el mismo para el tratamiento de enfermedades y trastornos relacionados con il-6r. |
| WO2010115995A2 (en) | 2009-04-10 | 2010-10-14 | Ablynx Nv | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders |
| CN102459332B (zh) | 2009-06-05 | 2015-08-19 | 埃博灵克斯股份有限公司 | 用于预防和/或治疗呼吸道感染的单价、二价和三价抗人呼吸道合胞病毒(hrsv)纳米抗体构建体 |
| SG10201700096VA (en) * | 2009-07-17 | 2017-02-27 | Bioatla Llc | Simultaneous, Integrated Selection And Evolution Of Antibody/Protein Performance And Expression In Production Hosts |
| GB0914691D0 (en) * | 2009-08-21 | 2009-09-30 | Lonza Biologics Plc | Immunoglobulin variants |
| US9139825B2 (en) | 2009-10-30 | 2015-09-22 | Novartis Ag | Universal fibronectin type III bottom-side binding domain libraries |
| WO2011064382A1 (en) | 2009-11-30 | 2011-06-03 | Ablynx N.V. | Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections |
| AU2011283646B2 (en) | 2010-07-30 | 2015-07-09 | Novartis Ag | Fibronectin cradle molecules and libraries thereof |
| JP5920835B2 (ja) | 2010-12-01 | 2016-05-18 | 田辺三菱製薬株式会社 | 無細胞翻訳系でＦａｂを提示しうるポリヌクレオチド構築物ならびにそれを用いたＦａｂの製造方法およびスクリーニング方法 |
| WO2013041722A1 (en) | 2011-09-23 | 2013-03-28 | Ablynx Nv | Prolonged inhibition of interleukin-6 mediated signaling |
| JP6415987B2 (ja) | 2012-03-02 | 2018-10-31 | アブリンクス エン．ヴェー． | シュードモナス・エルギノーサのＰｃｒＶに結合する単一可変ドメイン抗体 |
| USRE49477E1 (en) * | 2012-04-20 | 2023-03-28 | Thomas Jefferson University | Engineered antibody for inhibition of fibrosis |
| EP3929288A1 (en) | 2012-05-25 | 2021-12-29 | Chr. Hansen A/S | Variants of chymosin with improved milk-clotting properties |
| WO2014087010A1 (en) | 2012-12-07 | 2014-06-12 | Ablynx N.V. | IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE |
| KR101600902B1 (ko) | 2012-12-11 | 2016-03-10 | 주식회사 셀레믹스 | 코돈 조합화 및 변이유발을 이용한 유전자 라이브러리의 합성 방법 |
| US20140314741A1 (en) * | 2013-04-18 | 2014-10-23 | Developmen Center For Biotechnology | Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases |
| CA2924520C (en) * | 2013-11-01 | 2023-09-26 | Ibc Pharmaceuticals, Inc. | Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease |
| CN104805507B (zh) * | 2014-01-29 | 2019-01-22 | 杭州康万达医药科技有限公司 | 噬菌体展示文库及其应用和制备方法 |
| RU2739004C1 (ru) | 2014-02-26 | 2020-12-21 | Кхр. Хансен А/С | Варианты химозина с улучшенными молокосвертывающими свойствами |
| CA2963712A1 (en) | 2014-10-21 | 2016-04-28 | Ablynx Nv | Treatment of il-6r related diseases |
| EP3310914B1 (en) | 2015-06-22 | 2022-04-06 | Chr. Hansen A/S | Variants of chymosin with improved properties |
| AU2016315269B2 (en) | 2015-08-31 | 2021-09-23 | Chr. Hansen A/S | Variants of chymosin with improved properties |
| JP6803619B2 (ja) * | 2016-01-08 | 2020-12-23 | 桃太郎源株式会社 | ＲＥＩＣ／Ｄｋｋ−３遺伝子およびチェックポイント阻害剤を用いた併用療法 |
| AR108526A1 (es) | 2016-05-19 | 2018-08-29 | Chr Hansen As | Variantes de quimosina con propiedades mejoradas de coagulación de la leche |
| AR108527A1 (es) | 2016-05-19 | 2018-08-29 | Chr Hansen As | Variantes de quimosina con propiedades mejoradas de coagulación de leche |
| CN117298260A (zh) * | 2016-09-02 | 2023-12-29 | 莱蒂恩技术公司 | 用DuoCAR治疗癌症的组合物和方法 |
| WO2019118918A1 (en) | 2017-12-15 | 2019-06-20 | Aleta Biotherapeutics Inc. | Cd19 variants |
| CN117672369A (zh) * | 2022-09-01 | 2024-03-08 | 珠海碳云智能科技有限公司 | 一种基于多肽芯片的抗体表位的高通量鉴定方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2079802C (en) * | 1990-04-05 | 2001-09-18 | Roberto Crea | Walk-through mutagenesis |
| WO1995023813A1 (en) * | 1994-03-04 | 1995-09-08 | Merck & Co., Inc. | In vitro antibody affinity maturation using alanine scanning mutagenesis |
| JP2003516755A (ja) * | 1999-12-15 | 2003-05-20 | ジェネンテック・インコーポレーテッド | ショットガン走査、すなわち機能性タンパク質エピトープをマッピングするための組み合わせ方法 |
-
2004
- 2004-06-25 US US10/877,467 patent/US20050136428A1/en not_active Abandoned
- 2004-06-25 CN CNA2004800229706A patent/CN1836041A/zh active Pending
- 2004-06-25 RU RU2005140664/13A patent/RU2005140664A/ru not_active Application Discontinuation
- 2004-06-25 ES ES04756045.3T patent/ES2609102T3/es not_active Expired - Lifetime
- 2004-06-25 KR KR1020057025136A patent/KR20060034650A/ko not_active Withdrawn
- 2004-06-25 JP JP2006517625A patent/JP4791960B2/ja not_active Expired - Lifetime
- 2004-06-25 CA CA2542192A patent/CA2542192C/en not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020306 patent/WO2005003345A2/en not_active Ceased
- 2004-06-25 EP EP04756045.3A patent/EP1660655B1/en not_active Expired - Lifetime
- 2004-06-25 BR BRPI0412007-8A patent/BRPI0412007A/pt not_active IP Right Cessation
- 2004-06-25 AU AU2004254352A patent/AU2004254352A1/en not_active Abandoned
-
2005
- 2005-12-21 IL IL172736A patent/IL172736A0/en unknown
- 2005-12-22 ZA ZA200510460A patent/ZA200510460B/xx unknown
-
2006
- 2006-01-06 NO NO20060108A patent/NO20060108L/no not_active Application Discontinuation
-
2011
- 2011-03-22 JP JP2011062697A patent/JP5358604B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1660655A2 (en) | 2006-05-31 |
| WO2005003345A3 (en) | 2005-03-24 |
| BRPI0412007A (pt) | 2006-08-15 |
| JP2007524390A (ja) | 2007-08-30 |
| JP5358604B2 (ja) | 2013-12-04 |
| JP4791960B2 (ja) | 2011-10-12 |
| CN1836041A (zh) | 2006-09-20 |
| US20050136428A1 (en) | 2005-06-23 |
| KR20060034650A (ko) | 2006-04-24 |
| EP1660655B1 (en) | 2016-11-02 |
| RU2005140664A (ru) | 2007-08-27 |
| JP2011182794A (ja) | 2011-09-22 |
| AU2004254352A1 (en) | 2005-01-13 |
| CA2542192A1 (en) | 2005-01-13 |
| WO2005003345A2 (en) | 2005-01-13 |
| ES2609102T3 (es) | 2017-04-18 |
| IL172736A0 (en) | 2006-04-10 |
| CA2542192C (en) | 2013-05-28 |
| ZA200510460B (en) | 2006-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005003345A3 (en) | Look-through mutagenesis | |
| BRPI0513155A (pt) | mutagênese por inserção para desenvolver polipeptìdeos alterados com propriedades realçadas | |
| Lomonte et al. | Strategies in ‘snake venomics’ aiming at an integrative view of compositional, functional, and immunological characteristics of venoms | |
| Venne et al. | An improved workflow for quantitative N‐terminal charge‐based fractional diagonal chromatography (ChaFRADIC) to study proteolytic events in Arabidopsis thaliana | |
| Ahn et al. | Accessing the reproducibility and specificity of pepsin and other aspartic proteases | |
| DE102010026094B4 (de) | Ein neues Verfahren zum Charakterisieren und multidimensionalen Darstellen des Faltungsvorgangs der Proteine | |
| Tsiatsiani et al. | Aspergillus niger prolyl endoprotease for hydrogen–deuterium exchange mass spectrometry and protein structural studies | |
| Jorge et al. | High‐sensitivity analysis of specific peptides in complex samples by selected MS/MS ion monitoring and linear ion trap mass spectrometry: application to biological studies | |
| Luxmi et al. | Cilia-based peptidergic signaling | |
| Wiezel et al. | In-depth venome of the Brazilian rattlesnake Crotalus durissus terrificus: an integrative approach combining its venom gland transcriptome and venom proteome | |
| Wang et al. | Reliable determination of site-specific in vivo protein N-glycosylation based on collision-induced MS/MS and chromatographic retention time | |
| WO2014150983A3 (en) | Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9 (pcsk9) | |
| Rogniaux et al. | Allergen relative abundance in several wheat varieties as revealed via a targeted quantitative approach using MS | |
| BR112013017363A2 (pt) | biblioteca de alphabody de cadeia única, mistura de bibliotecas de alphabody, ácido nucleico ou biblioteca de vetor, biblioteca de células hospedeiras, uso de uma biblioteca de alphabody de cadeia única, método para a produção de uma biblioteca de alphabody de cadeia única, método para a produção de um ou mais polipeptídeos de alphabody de cadeia única, polipeptíceo de alphabody de cadeia única, ácido nucleico, vetor e célula hospedeira | |
| Sun et al. | Identification and molecular mechanism of novel antioxidant peptide from fish sauce: A combined quantum chemistry and molecular simulation | |
| Lovric | Introducing proteomics: from concepts to sample separation, mass spectrometry and data analysis | |
| Babenko et al. | Novel bradykinin-potentiating peptides and three-finger toxins from viper venom: Combined NGS venom gland transcriptomics and quantitative venom proteomics of the Azemiops feae viper | |
| JP2019507341A5 (pt) | ||
| Ma et al. | Differential proteomic analysis of platelets suggested possible signal cascades network in platelets treated with salvianolic acid B | |
| Freitas et al. | New constitutive latex osmotin-like proteins lacking antifungal activity | |
| Surin et al. | Determination of amyloid core regions of insulin analogues fibrils | |
| Disela et al. | Characterisation of the E. coli HMS174 and BLR host cell proteome to guide purification process development | |
| WO2005116660A3 (en) | Methods for making and using mass tag standards for quantitative proteomics | |
| Chang et al. | Advancements in Identification of Low‐Molecular‐Weight Peptides in Food Protein Hydrolysates | |
| NZ752437A (en) | Multi-protease method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |